{ "schemaVersion": "ready-scan.agent-evidence.v1", "protocolVersion": "ready-scan.agent-return.v1", "entity": { "id": "urn:readyscan:entity:ladies-first-q141497801", "slug": "ladies-first-q141497801", "name": "Ladies First", "lifecycle": "active", "revision": "fnv1a64:cfec4b40474c5f87" }, "self": "https://readyscan.ai/api/v1/ai-search/entities/ladies-first-q141497801/evidence", "evidenceRevision": "fnv1a64:5264564a0aff5f6c", "asOf": "2026-10-22", "ownershipState": "public_sourced_unclaimed", "provenance": { "snapshotId": "ladies-first-q141497801-content-3e339beb381cb0ea-snapshot", "sourceId": "ready-scan-subjects", "sourceRecordId": "Q141497801", "sourceRevisionId": "Q141497801:content:b6fc1e32463ee19d", "sourceContentHash": "fnv1a64:d976dc514e1f9004", "recordRevisionId": "Q141497801:content:b6fc1e32463ee19d", "recordContentHash": "fnv1a64:d8895ddb898ce6ca", "sourceCanonicalUrl": "https://itsladiesfirst.com/", "sourceModifiedAt": "2026-10-22T09:37:32.207Z", "observedOn": "2026-10-22", "permission": { "basis": "public_information", "evidenceUrl": "https://itsladiesfirst.com/" }, "attributionUrl": "https://itsladiesfirst.com/" }, "assertions": [ { "evidenceId": "ev-content-native-digital-agencies-e42242390f8d67c0-a-ccdcfc0e61d32da193e2", "claimId": "content-native-digital-agencies-e42242390f8d67c0-a-ccdcfc0e61d32da193e2", "claimText": "“Women-first online care for GLP-1 weight management, hair loss, and longevity — honest, transparent pricing and provider-reviewed treatment plans.”", "position": "supports", "sources": [ { "sourceId": "source-record", "title": "Ladies First website", "publisher": "itsladiesfirst.com", "url": "https://itsladiesfirst.com/", "accessedOn": "2026-10-22", "sourceRevision": "Q141497801:content:b6fc1e32463ee19d" } ] }, { "evidenceId": "ev-content-native-digital-agencies-e42242390f8d67c0-a-6e8aa824a023737fcda4", "claimId": "content-native-digital-agencies-e42242390f8d67c0-a-6e8aa824a023737fcda4", "claimText": "“Compounded semaglutide starts as low as $169 per 28 days on a 52-week plan — $189 on a 12-week plan, or $199 every 28 days on the flexible plan. Compounded tirzepatide starts as low as $249 per 28 days on a 52-week plan — $269 on 12-week, or $279 every 28 days on the flexible plan.”", "position": "supports", "sources": [ { "sourceId": "source-record", "title": "Ladies First website", "publisher": "itsladiesfirst.com", "url": "https://itsladiesfirst.com/", "accessedOn": "2026-10-22", "sourceRevision": "Q141497801:content:b6fc1e32463ee19d" } ] }, { "evidenceId": "ev-content-native-digital-agencies-e42242390f8d67c0-a-82e24eadb56aa495705d", "claimId": "content-native-digital-agencies-e42242390f8d67c0-a-82e24eadb56aa495705d", "claimText": "“Payment is collected when you complete your medical intake — your exact price is shown before you enter any payment details. A licensed medical provider then reviews your information within 24–48 hours, and treatment ships only if they approve.”", "position": "supports", "sources": [ { "sourceId": "source-record", "title": "Ladies First website", "publisher": "itsladiesfirst.com", "url": "https://itsladiesfirst.com/", "accessedOn": "2026-10-22", "sourceRevision": "Q141497801:content:b6fc1e32463ee19d" } ] }, { "evidenceId": "ev-content-native-digital-agencies-e42242390f8d67c0-a-ef9498a6a99578d11463", "claimId": "content-native-digital-agencies-e42242390f8d67c0-a-ef9498a6a99578d11463", "claimText": "“They are different regulatory categories. Compounded semaglutide is a separate preparation made by state-licensed compounding pharmacies — it is not FDA-approved, and trial results from the branded products don’t automatically transfer to it. Whether a compounded or brand-name option is appropriate for you is a medical decision your provider makes.”", "position": "supports", "sources": [ { "sourceId": "source-record", "title": "Ladies First website", "publisher": "itsladiesfirst.com", "url": "https://itsladiesfirst.com/", "accessedOn": "2026-10-22", "sourceRevision": "Q141497801:content:b6fc1e32463ee19d" } ] }, { "evidenceId": "ev-content-native-digital-agencies-e42242390f8d67c0-a-076a271a97da7c0784e1", "claimId": "content-native-digital-agencies-e42242390f8d67c0-a-076a271a97da7c0784e1", "claimText": "“Ladies First is a women's telehealth service: you complete an online intake, a medical provider licensed in your state reviews it, and if treatment is appropriate, medication ships to your door. Programs cover weight loss with GLP-1 medications, hair-loss treatment, and longevity & energy options — and in every one of them, a provider decides what fits, not a menu.”", "position": "supports", "sources": [ { "sourceId": "source-2544c2e4a846261f", "title": "itsladiesfirst.com/faq/", "publisher": "itsladiesfirst.com", "url": "https://itsladiesfirst.com/faq/", "accessedOn": "2026-10-22", "sourceRevision": "Q141497801:content:b6fc1e32463ee19d" } ] }, { "evidenceId": "ev-content-native-digital-agencies-e42242390f8d67c0-a-b2f5e45526aebec93490", "claimId": "content-native-digital-agencies-e42242390f8d67c0-a-b2f5e45526aebec93490", "claimText": "“Yes. Ladies First is a women's telehealth platform certified by LegitScript, an independent healthcare certification service (certificate 47682256) — the same certification Google, Meta, and Microsoft require before a healthcare business is allowed to advertise.”", "position": "supports", "sources": [ { "sourceId": "source-2544c2e4a846261f", "title": "itsladiesfirst.com/faq/", "publisher": "itsladiesfirst.com", "url": "https://itsladiesfirst.com/faq/", "accessedOn": "2026-10-22", "sourceRevision": "Q141497801:content:b6fc1e32463ee19d" } ] }, { "evidenceId": "ev-content-native-digital-agencies-e42242390f8d67c0-a-36d2d137ba28b4d9ed7a", "claimId": "content-native-digital-agencies-e42242390f8d67c0-a-36d2d137ba28b4d9ed7a", "claimText": "“Visit LegitScript's website and search for itsladiesfirst.com, or use the verification link on our LegitScript certification page. Our certificate ID is 47682256. LegitScript is an independent service that reviews and monitors healthcare businesses for legal compliance and transparent practices, so its certification is an outside check on who we are — not something we grade ourselves.”", "position": "supports", "sources": [ { "sourceId": "source-2544c2e4a846261f", "title": "itsladiesfirst.com/faq/", "publisher": "itsladiesfirst.com", "url": "https://itsladiesfirst.com/faq/", "accessedOn": "2026-10-22", "sourceRevision": "Q141497801:content:b6fc1e32463ee19d" } ] }, { "evidenceId": "ev-content-native-digital-agencies-e42242390f8d67c0-a-6223d139175e6656d782", "claimId": "content-native-digital-agencies-e42242390f8d67c0-a-6223d139175e6656d782", "claimText": "“Honestly: they're supporting players, not headliners.”", "position": "supports", "sources": [ { "sourceId": "source-2544c2e4a846261f", "title": "itsladiesfirst.com/faq/", "publisher": "itsladiesfirst.com", "url": "https://itsladiesfirst.com/faq/", "accessedOn": "2026-10-22", "sourceRevision": "Q141497801:content:b6fc1e32463ee19d" } ] } ], "contradictionState": "none_recorded", "ambiguityState": "none_recorded", "relations": { "discovery": "https://readyscan.ai/api/v1/ai-search/discovery", "evidence": "https://readyscan.ai/api/v1/ai-search/entities/ladies-first-q141497801/evidence" }, "limitations": [ "This document connects published company information to its retained source references. Unmatched IDs remain unknown; reading it does not refresh the sources." ] }